Antiva Biosciences, Inc.
New Filing
CIK: 0001563355·Biotechnology·DELAWARE·Filed: Apr 5, 2017
Total Offering
$22,341,512
Amount Sold
$11,140,756
Investors
13
First Sale
Feb 15, 2017
Offering Details
- Type
- Equity, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2012
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Gail Maderis | Related Person |
| Keith Bley | Related Person |
| Michael D. Cannon | Related Person |
| Oranee Daniels | Related Person |
| Wendee S. Hutton | Related Person |
| Steven P. James | Related Person |
| David Kabakoff | Related Person |
| Vinzenz Ploerer | Related Person |
| Sarah Walter | Related Person |
Company
SEC Filing
0001563355-17-000003
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free